A clinician is comparing two patients: Patient A reports 6 weeks of severe symptoms meeting full MDD criteria. Patient B reports 3 years of persistent low mood, poor concentration, low energy, and hopelessness, with only 2–3 additional symptoms at any one time. Which patient meets criteria for Persistent Depressive Disorder, and what is the defining distinction?
APatient A meets PDD criteria because severity of symptoms is the defining feature of PDD
BPatient B meets PDD criteria — PDD is defined by duration (at least 2 years with depressed mood most days) and requires fewer symptoms than MDD
CBoth patients meet PDD criteria, which overlaps completely with MDD
DNeither meets PDD criteria — Patient A has MDD and Patient B does not have enough symptoms for any diagnosis
PDD (formerly dysthymia) is defined primarily by chronicity, not severity: depressed mood present most of the day, more days than not, for at least 2 years, with only two additional symptoms required. Patient B's 3-year course with a low symptom count is the signature profile. Patient A's 6-week severe episode fits MDD (which requires ≥5 symptoms for 2 weeks), not PDD. PDD trades severity for duration — it requires fewer symptoms but for far longer, which profoundly changes the patient's relationship to their depression.
Question 2 Multiple Choice
A patient with a 4-year history of PDD is treated with an SSRI for a superimposed major depressive episode. Symptoms improve substantially over 3 months, but the patient never reaches full euthymia and continues reporting low energy, poor concentration, and mild hopelessness. The clinician attributes this to an inadequate SSRI dose. What is the more likely explanation?
AThe SSRI returned the patient to their PDD baseline — the underlying chronic disorder was never addressed, so full recovery to euthymia is not expected from MDE treatment alone
BThe patient has developed treatment-resistant MDD and needs ECT
CThe patient's remaining symptoms are normal depressive traits that should not be treated
DSSRIs are ineffective for any form of depression lasting more than one year
This is the 'double depression' scenario: a major depressive episode superimposed on a PDD baseline. Treating the MDE successfully returns the patient to their chronically depressed PDD baseline — which still involves real symptoms. This incomplete recovery is frequently misattributed to inadequate MDE treatment rather than recognized as the untreated PDD. The correct response is to diagnose and treat the PDD itself, which requires sustained combined treatment targeting the chronic baseline, not just the acute episode.
Question 3 True / False
Persistent Depressive Disorder requires the same number of depressive symptoms as Major Depressive Disorder, but the symptoms should persist for at least 2 years.
TTrue
FFalse
Answer: False
PDD has a lower symptom threshold than MDD. MDD requires five or more symptoms from the diagnostic list. PDD requires depressed mood most of the day, more days than not, for at least 2 years, plus only two additional symptoms from a list including poor appetite, insomnia/hypersomnia, low energy, low self-esteem, poor concentration, and hopelessness. PDD trades severity (fewer required symptoms) for chronicity (much longer duration). A patient can have subthreshold symptoms that would not meet MDD criteria but still qualify for PDD.
Question 4 True / False
Patients with PDD often present not as acutely suffering but as describing their depression as 'just how I am' — incorporating chronic low mood into their self-concept rather than recognizing it as a treatable disorder.
TTrue
FFalse
Answer: True
This identity-level normalization is a core clinical feature of PDD that distinguishes it from typical MDD presentations. Because PDD has often been present since before the patient can remember feeling otherwise, they may interpret persistent low mood, low energy, and pessimism as personality traits rather than symptoms. This is itself a therapeutic target: before patients can engage meaningfully with treatment, they must first recognize their chronic state as a disorder, not an immutable aspect of who they are. CBASP, designed specifically for PDD, directly addresses this pattern.
Question 5 Short Answer
Explain why the 2-year duration criterion in PDD matters clinically — specifically, how does chronicity change a patient's relationship to their depression compared to someone experiencing an acute major depressive episode?
Think about your answer, then reveal below.
Model answer: When depression lasts 2+ years, patients often have no clear memory of feeling otherwise. This makes it impossible to contrast their current state with a remembered euthymic baseline — how most people recognize they are depressed. Instead, chronic low mood becomes the reference point for normal, and patients interpret their symptoms as personality traits (pessimism, low energy, poor self-esteem) rather than as a disorder. An acute MDE, by contrast, represents a change from a known prior state, making its pathological character self-evident.
This normalization has direct therapeutic implications. Treating PDD requires first addressing the identity-level reframing — helping the patient understand that their chronic state is a treatable condition, not who they are. Without this, engagement with therapy or medication is shallow. The chronicity also produces deeper neurobiological adaptation (suggesting why PDD often needs longer treatment than MDD) and accumulated interpersonal consequences (social withdrawal, learned helplessness) requiring targeted work — which is why CBASP was developed specifically for chronic depression.